Origen de la red de primer grado Mark Farmery.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
11
| Public Company | Pharmaceuticals: Major | 11 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Mark Farmery a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| AEROCRINE AB | Electronic Equipment/Instruments | Founder | |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| MEDIVIR AB | Pharmaceuticals: Major | Chairman Chairman | |
Carmeda AB
 Carmeda AB Pharmaceuticals: MajorHealth Technology Carmeda AB develops, manufactures and markets biocompatible coating technologies. Its technologies address complications such as thrombosis, inflammatory response, and infection associated with the use of medical devices. The company was founded by Karl Olov Peter Larm and Per Olsson in 1984 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Toronto | College/University | Graduate Degree | |
| Stockholm School of Economics | College/University | Graduate Degree Graduate Degree | |
| London School of Economics & Political Science | College/University | Undergraduate Degree | |
| University of Lund | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
| Healthcap III Sidefund GP AB | Investment Managers | Director/Board Member | |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
| AROCELL AB | Medical Specialties | Founder | |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| LIDDS AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
Attgeno AB
 Attgeno AB Pharmaceuticals: MajorHealth Technology ATTGENO AB develops, manufactures, and trades pharmaceutical drugs and electronic apparatus. Its product, Supernitro, is a vasodilator indicated for the treatment of acute pulmonary hypertension associated with major cardiac surgery. The company is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman | |
Maas Biolab LLC
 Maas Biolab LLC Pharmaceuticals: MajorHealth Technology Maas Biolab LLC manufactures vaccines for chronic neurodegenerative diseases such as amyotrophic lateral sclerosis, Parkinson's, and Alzheimer's. The American company was founded by Marcus Keep and Eskil Elmér, with Marcus Keep serving as CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Laccure AB
 Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Generic | Founder | |
| GUARD THERAPEUTICS INTERNATIONAL AB | Pharmaceuticals: Major | Chairman | |
| XINTELA AB | Biotechnology | Chairman | |
| Stanbridge Corp. BV | Chief Executive Officer | ||
| ACUCORT AB | Pharmaceuticals: Major | Chairman | |
| Preelumina Diagnostics AB | Chairman | ||
| Medical Prognosis Institute, Inc. | Director/Board Member | ||
Monocl AB
 Monocl AB Internet Software/ServicesTechnology Services Monocl AB develops cloud-based stakeholder platform. Its areas include business development, valuation, and communication. The company was founded by Björn Carlsson and Tobias Thornblad in 2011 and is headquartered in Gothenburg, Sweden. | Internet Software/Services | Chairman | |
| Pulsetten AB | Chief Executive Officer | ||
| INTELLEGO TECHNOLOGIES AB | Electronic Components | Chairman | |
SAGA Diagnostics AB
 SAGA Diagnostics AB Medical/Nursing ServicesHealth Services Saga Diagnostics AB operates as a personalized cancer medicine and disease monitoring company. The firm's services include Gene Mutation analysis, circulating tumor DNA and Chromosome analysis. The company was founded by Lao Saal and Anthony George in 2016 and is headquartered in Lund, Sweden. | Medical/Nursing Services | Chairman | |
| Business Research Life Sciences Ltd. | Director/Board Member | ||
| Mordin AB | Corporate Officer/Principal | ||
Trophea AB
 Trophea AB Miscellaneous Commercial ServicesCommercial Services Trophea AB provides medical need for a treatment of skin atrophy caused by long-term use of topical glucocorticoids. The company is headquartered in Helsingborg, Sweden. | Miscellaneous Commercial Services | Founder | |
ImmuneBiotech Medical Sweden AB
 ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chairman | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Targinta AB
 Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Biotechnology | Chairman | |
ADDI Medical AB
 ADDI Medical AB Packaged SoftwareTechnology Services ADDI Medical AB develops a communication platform for the healthcare industry. The private company is based in Stockholm, Sweden. | Packaged Software | Director/Board Member | |
| Addi Optioner AB | Director/Board Member | ||
| GALECTO, INC. | Pharmaceuticals: Major | Chairman | |
| Galecto Biotech AB | Chairman | ||
| Bioworks AB | Chairman | ||
CarryGenes Therapeutics AB
 CarryGenes Therapeutics AB Miscellaneous Commercial ServicesCommercial Services CarryGenes Therapeutics AB engages in the research and development of biotechnology. The private company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Chairman | |
Eir Ventures Partners AB
 Eir Ventures Partners AB Investment ManagersFinance Eir Ventures Partners AB (Eir Ventures) is an independent venture capital firm founded in 2020 by Dr Magnus Persson, Dr Stephan Christgau, Andreas Segerros and Dr Amanda Hayward. The firm is headquartered in Stockholm with an additional office in Copenhagen, Denmark. | Investment Managers | Chairman | |
| P O Persson i Lidingö AB | Director/Board Member | ||
| Duomedix AB | Corporate Officer/Principal | ||
| Merigen AB | Corporate Officer/Principal | ||
| OVB Freehold Ltd. | Director/Board Member | ||
| Immodulate Pharma AB | Director/Board Member | ||
| Sls Ventures AB | Director/Board Member | ||
| Lundoch Diagnostics AB | Chairman | ||
Preelumina AB
 Preelumina AB Pharmaceuticals: MajorHealth Technology PrePreelumina AB develops pharmaceutical products for diagnosis of preeclampsia. The firm investigates the mechanisms behind the development of preeclampsia and identified a unique treatment method based on an endogenous protein. The company was founded by Tomas Jörgen Eriksson in 2008 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chairman |
Estadísticas
Internacional
| Suecia | 42 |
| Reino Unido | 4 |
| Estados Unidos | 4 |
| Canadá | 2 |
| Bélgica | 2 |
Sectorial
| Health Technology | 18 |
| Finance | 6 |
| Consumer Services | 5 |
| Electronic Technology | 3 |
| Health Services | 3 |
Operativa
| Director/Board Member | 119 |
| Chairman | 53 |
| Independent Dir/Board Member | 35 |
| Chief Executive Officer | 22 |
| Corporate Officer/Principal | 21 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Mark Farmery
- Conexiones Empresas
